~~<i id='A3C4B86476'><strike id='A3C4B86476'><tt id='A3C4B86476'><pre id='A3C4B86476'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：fashion 2025-09-30 23:06:32 - browse：5116

An advisory panel to the Food and Drug Administration delivered a split decision on a surgical system used in a controversial blood pressure treatment called renal denervation.

The panel, whose advice the FDA typically follows, voted that the system developed by ReCor Medical was safe and effective. It voted that the benefits of a system developed by Medtronic, however, did not outweigh the risks.

“While this is a very safe procedure, the efficacy was mild at best,” Keith Allen, director of surgical research at St. Luke’s Hospital of Kansas City, said regarding Medtronic’s device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： How to convince healthy people to buy insurance

focus

hotspot

Wikipedia

focus

hotspot

knowledge

1:14InthisOct.13,2022,filephoto,servicemembersofRussianprivatemilitarycompanyWagnerGroupbringcombatg

WSS

The story of mRNA: From a loose idea to a tool that may help curb Covid

How to convince healthy people to buy insurance

Infant mortality in U.S. rose last year for first time in decades: CDC

New guidelines on severe brain injury complicate already difficult decisions

Ask STAT: What do you want to know about ChatGPT in medicine?

#NeedHerScience: shining a light on gender disparities in medicine

focus

leisure time

focus

Affirmative action in medical school literally saved lives

The health care issue Democrats can’t solve: hospital reform

What does generative AI mean for health care? We asked experts

The science behind Janet Jackson's pregnancy at 49

Medical leaders decry Supreme Court decision on affirmative action

Weight bias in eating disorder treatment complicated by new weight loss drugs

What does generative AI mean for health care? We asked experts

Kidney transplant patients stopped immunosuppressants in trial

How one medical school became remarkably diverse

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

hotspot

All of Us, NIH's precision medicine initiative, gets a big boost

Ask STAT: What do you want to know about ChatGPT in medicine?

How to convince healthy people to buy insurance

Infant mortality in U.S. rose last year for first time in decades: CDC

The science behind Janet Jackson's pregnancy at 49

Life sciences investors close nearly $6 billion in new funds

Wikipedia

focus

hotspot

knowledge